FOXP3 and systemic sclerosis: In this study, we first verified the previous research results in our group, showing that CD4+CD25+FoxP3+ Treg levels are elevated in patients with naïve SSc; however, interestingly, these CD4+CD25+FoxP3+ Tregs lack their normal immune suppression capacity.